Sean O. Todd

Enhancing the Thermostability and Immunogenicity of a Respiratory Syncytial Virus (RSV) Live-Attenuated Vaccine by Incorporating Unique RSV Line19F Protein Residues

M. Moore, C. Rostad, Christopher C. Stobart, 2017, Journal of Virology.

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

A. Oomens, M. Moore, L. Haynes, 2017, Journal of Virology.

Prophylaxis with a Respiratory Syncytial Virus (RSV) Anti-G Protein Monoclonal Antibody Shifts the Adaptive Immune Response to RSV rA2-line19F Infection from Th2 to Th1 in BALB/c Mice

S. Boyoglu-Barnum, L. Anderson, Patricia A Jorquera, 2014, Journal of Virology.

A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice

S. Boyoglu-Barnum, Patricia A Jorquera, R. Tripp, 2013, Journal of Virology.

An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.

S. Boyoglu-Barnum, L. Anderson, R. Tripp, 2015, Virology.

EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression

R. Plemper, R. Peebles, R. Villenave, 2016, PLoS pathogens.